Cell-based Immunotherapy Against Gliomas: From Bench to Bedside
Authors:
- M Hannah DegelingMDM Hannah Degeling
- Bakhos A TannousBTBakhos A Tannous
Open Access
- 1 July 2013
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 21 (7) , 1297-1305
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Conditional probability of long‐term survival in glioblastomaCancer, 2012
- Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsExpert Opinion on Biological Therapy, 2012
- Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of GlioblastomaJournal of Immunotherapy, 2012
- Dermal Substitutes Do Well on Dura: Comparison of Split Skin Grafting +/− Artificial Dermis for Reconstruction of Full-thickness Calvarial DefectsClinics in Plastic Surgery, 2012
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United StatesClinical Cancer Research, 2010
- Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapyVaccine, 2010
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007
- Combined Immunostimulation and Conditional Cytotoxic Gene Therapy Provide Long-term Survival in a Large Glioma ModelCancer Research, 2005
- Results of a Pilot Study Involving the Use of an Antisense Oligodeoxynucleotide Directed Against the Insulin-Like Growth Factor Type I Receptor in Malignant AstrocytomasJournal of Clinical Oncology, 2001
- Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cellsNature Cell Biology, 1999